MoneyWorks4Me

Ajanta Pharma informs about earnings conference call

12 Jan 2026 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, Ajanta Pharma has informed that it enclosed the schedule of Earnings Conference Call to be held on 30th Jan 2026, post Board meeting. 

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1859.90
Dr. Reddys Labs. 1172.35
Cipla 1380.20
Lupin 2079.95
Zydus Lifesciences 1136.70
View more..